Rs.15000 Million New Monoclonal Antibodies Mfg. Unit in Sangareddy district, Telangana
A new biologics manufacturing complex is planned across a 10-hectare site in Kandi Mandal, Sangareddy, with total built-up area of over 55,747 sqm dedicated to R&D and manufacturing of monoclonal antibodies (mAbs). The proposal, categorized under B2 EIA norms, is currently under verification with the Ministry of Environment, Forest and Climate Change ahead of Environmental Clearance.
View project